<!-- SOFAScoreCalculatorPage.vue -->
<script setup lang="ts">
/**
 * @file SOFAScoreCalculatorPage.vue
 * @description SOFA (Sequential Organ Failure Assessment) Score Calculator
 * @author Vasile Chifeac
 * @created 2025-11-13
 */

import { ref, computed } from 'vue';

interface SOFAScores {
  respiration: number;
  coagulation: number;
  liver: number;
  cardiovascular: number;
  cns: number;
  renal: number;
}

const initialScores: SOFAScores = {
  respiration: 0,
  coagulation: 0,
  liver: 0,
  cardiovascular: 0,
  cns: 0,
  renal: 0,
};

const scores = ref<SOFAScores>({ ...initialScores });

const totalScore = computed(() => {
  return Object.values(scores.value).reduce((sum, val) => sum + val, 0);
});

/**
 * Get color code based on SOFA severity
 * @param score - Total SOFA score (0-24)
 * @returns Quasar color name (green/orange/red)
 */
const getScoreColor = (score: number): string => {
  if (score < 6) return 'green';
  if (score < 10) return 'orange';
  return 'red';
};

/**
 * Get mortality risk description based on SOFA score
 * @param score - Total SOFA score (0-24)
 * @returns Mortality risk percentage string
 */
const getMortalityRisk = (score: number): string => {
  if (score < 2) return '<10% Mortality';
  if (score < 6) return '15-20% Mortality';
  if (score < 10) return '40-50% Mortality';
  if (score < 15) return '>80% Mortality';
  return '>90% Mortality';
};

/**
 * Reset all organ scores to initial state (0)
 */
const resetForm = () => {
  scores.value = { ...initialScores };
};
</script>

<template>
  <div class="q-mb-lg">
    <q-breadcrumbs>
      <q-breadcrumbs-el icon="home" @click="$router.push('/')" class="cursor-pointer" />
      <q-breadcrumbs-el label="SOFA Score" />
    </q-breadcrumbs>
    <h4 class="text-h4 text-primary q-mt-md q-mb-none">üè• SOFA Score Calculator</h4>
    <p class="text-subtitle1 text-grey-7">
      Sequential Organ Failure Assessment - Multi-organ dysfunction evaluation in intensive care
    </p>
  </div>

  <q-banner class="bg-blue-1 q-mb-md" rounded>
    <template v-slot:avatar>
      <q-icon name="local_hospital" color="primary" />
    </template>
    <div class="text-body2">
      <strong>SOFA Score:</strong> Prognostic system to assess severity of organ dysfunction in
      critically ill patients. 6 organ systems, score 0-4 each, total 0-24 points.
    </div>
  </q-banner>

  <div class="row q-gutter-md">
    <div class="col-12 col-md-5">
      <q-card flat bordered>
        <q-card-section>
          <h6 class="text-h6 q-ma-none q-mb-md">üìù Organ Parameters</h6>

          <!-- Respiration -->
          <div class="q-mb-md">
            <div class="text-subtitle2 text-weight-bold q-mb-xs">
              <q-icon name="air" color="cyan" size="xs" class="q-mr-xs" />
              Respiration (PaO‚ÇÇ/FiO‚ÇÇ)
            </div>
            <q-option-group
              v-model="scores.respiration"
              :options="[
                { label: '‚â•400', value: 0 },
                { label: '<400', value: 1 },
                { label: '<300', value: 2 },
                { label: '<200 with respiratory support', value: 3 },
                { label: '<100 with respiratory support', value: 4 },
              ]"
              color="primary"
              size="sm"
              dense
            />
          </div>

          <!-- Coagulation -->
          <div class="q-mb-md">
            <div class="text-subtitle2 text-weight-bold q-mb-xs">
              <q-icon name="bloodtype" color="red" size="xs" class="q-mr-xs" />
              Coagulation (Platelets √ó10¬≥/ŒºL)
            </div>
            <q-option-group
              v-model="scores.coagulation"
              :options="[
                { label: '‚â•150', value: 0 },
                { label: '<150', value: 1 },
                { label: '<100', value: 2 },
                { label: '<50', value: 3 },
                { label: '<20', value: 4 },
              ]"
              color="primary"
              size="sm"
              dense
            />
          </div>

          <!-- Liver -->
          <div class="q-mb-md">
            <div class="text-subtitle2 text-weight-bold q-mb-xs">
              <q-icon name="spa" color="orange" size="xs" class="q-mr-xs" />
              Liver (Bilirubin mg/dL)
            </div>
            <q-option-group
              v-model="scores.liver"
              :options="[
                { label: '<1.2', value: 0 },
                { label: '1.2-1.9', value: 1 },
                { label: '2.0-5.9', value: 2 },
                { label: '6.0-11.9', value: 3 },
                { label: '‚â•12.0', value: 4 },
              ]"
              color="primary"
              size="sm"
              dense
            />
          </div>

          <!-- Cardiovascular -->
          <div class="q-mb-md">
            <div class="text-subtitle2 text-weight-bold q-mb-xs">
              <q-icon name="favorite" color="pink" size="xs" class="q-mr-xs" />
              Cardiovascular (MAP/Vasopressors)
            </div>
            <q-option-group
              v-model="scores.cardiovascular"
              :options="[
                { label: 'MAP ‚â•70 mmHg', value: 0 },
                { label: 'MAP <70 mmHg', value: 1 },
                { label: 'Dopamine ‚â§5 or Dobutamine any', value: 2 },
                { label: 'Dopamine >5 OR Epinephrine ‚â§0.1 OR Norepinephrine ‚â§0.1', value: 3 },
                { label: 'Dopamine >15 OR Epinephrine >0.1 OR Norepinephrine >0.1', value: 4 },
              ]"
              color="primary"
              size="sm"
              dense
            />
          </div>

          <!-- CNS -->
          <div class="q-mb-md">
            <div class="text-subtitle2 text-weight-bold q-mb-xs">
              <q-icon name="psychology" color="purple" size="xs" class="q-mr-xs" />
              Central Nervous System (GCS)
            </div>
            <q-option-group
              v-model="scores.cns"
              :options="[
                { label: 'GCS 15', value: 0 },
                { label: 'GCS 13-14', value: 1 },
                { label: 'GCS 10-12', value: 2 },
                { label: 'GCS 6-9', value: 3 },
                { label: 'GCS <6', value: 4 },
              ]"
              color="primary"
              size="sm"
              dense
            />
          </div>

          <!-- Renal -->
          <div class="q-mb-md">
            <div class="text-subtitle2 text-weight-bold q-mb-xs">
              <q-icon name="water_drop" color="blue" size="xs" class="q-mr-xs" />
              Renal (Creatinine mg/dL or Urine Output mL/day)
            </div>
            <q-option-group
              v-model="scores.renal"
              :options="[
                { label: '<1.2', value: 0 },
                { label: '1.2-1.9', value: 1 },
                { label: '2.0-3.4', value: 2 },
                { label: '3.5-4.9 or <500 mL/day', value: 3 },
                { label: '‚â•5.0 or <200 mL/day', value: 4 },
              ]"
              color="primary"
              size="sm"
              dense
            />
          </div>

          <q-btn
            @click="resetForm"
            color="negative"
            size="md"
            class="full-width"
            icon="refresh"
            outline
          >
            Reset
          </q-btn>
        </q-card-section>
      </q-card>
    </div>

    <div class="col-12 col-md-6">
      <q-card flat bordered>
        <q-card-section>
          <h6 class="text-h6 q-ma-none q-mb-md">üìà SOFA Score Result</h6>

          <div class="text-center q-mb-lg">
            <div class="text-h2" :class="'text-' + getScoreColor(totalScore)">
              {{ totalScore }}
            </div>
            <div class="text-subtitle1 text-grey-7"><strong>Total Score</strong> (0-24)</div>
            <q-chip :color="getScoreColor(totalScore)" text-color="white" class="text-h6 q-mt-sm">
              {{ getMortalityRisk(totalScore) }}
            </q-chip>
          </div>

          <q-card flat bordered class="q-mb-md" :class="'bg-' + getScoreColor(totalScore) + '-1'">
            <q-card-section>
              <div class="text-subtitle2 text-weight-bold q-mb-sm">
                <q-icon name="medical_services" size="sm" class="q-mr-xs" />
                Clinical Interpretation:
              </div>
              <p class="text-body2 q-ma-none">
                SOFA {{ totalScore }}: {{ getMortalityRisk(totalScore) }} in-hospital mortality
                risk. Serial monitoring (every 24-48h) to assess trend. ŒîScore +2 points indicates
                significant deterioration.
              </p>
            </q-card-section>
          </q-card>

          <!-- ======================================================== -->
          <!-- SOFA SCORE COMPLETE SCIENTIFIC DOCUMENTATION            -->
          <!-- ======================================================== -->

          <!-- 1Ô∏è‚É£ DEFINITION AND CLINICAL SIGNIFICANCE -->
          <q-expansion-item
            icon="info"
            color="medical-mint"
            label="Definition and Clinical Significance"
            class="q-mt-md"
            header-class="bg-blue-1 text-blue-9"
          >
            <q-card flat class="q-pa-md bg-blue-1">
              <div class="text-body2">
                <p class="text-weight-bold text-h6 q-mb-sm">Historical Origin</p>
                <p>
                  The <strong>SOFA (Sequential Organ Failure Assessment) Score</strong> was
                  developed in <strong>1996</strong> by
                  <strong
                    >Jean-Louis Vincent and the Sepsis-related Organ Failure Assessment Working
                    Group</strong
                  >
                  at the European Society of Intensive Care Medicine consensus conference.
                </p>
                <p class="q-mt-md">
                  <strong>Original objective:</strong> Create a simple, objective system to describe
                  and quantify the degree of organ dysfunction over time in critically ill patients,
                  particularly those with sepsis.
                </p>
                <p class="q-mt-md">
                  <strong>Key characteristics:</strong>
                </p>
                <ul class="q-ml-md">
                  <li>‚úÖ Assesses <strong>6 major organ systems</strong> independently</li>
                  <li>
                    ‚úÖ Each organ scored <strong>0-4 points</strong> based on severity of
                    dysfunction
                  </li>
                  <li>‚úÖ Total score <strong>0-24 points</strong> (higher = worse prognosis)</li>
                  <li>
                    ‚úÖ Can be calculated <strong>repeatedly</strong> to track trajectory (delta
                    SOFA)
                  </li>
                  <li>
                    ‚úÖ Validated predictor of <strong>ICU mortality</strong> (AUROC 0.74-0.86)
                  </li>
                </ul>
              </div>

              <q-separator class="q-my-md" />

              <div class="text-body2">
                <p class="text-weight-bold text-h6 q-mb-sm">Clinical Applications</p>
                <p><strong>When to use:</strong></p>
                <ul class="q-ml-md">
                  <li>
                    ÔøΩ <strong>ICU admission triage:</strong> Baseline SOFA score for severity
                    stratification
                  </li>
                  <li>
                    üìà <strong>Serial monitoring:</strong> Daily SOFA scores to detect
                    deterioration/improvement
                  </li>
                  <li>
                    ü¶† <strong>Sepsis diagnosis (Sepsis-3):</strong> SOFA ‚â•2 points = organ
                    dysfunction criterion
                  </li>
                  <li>
                    üî¨ <strong>Clinical trials:</strong> Standardized severity measure and outcome
                    predictor
                  </li>
                  <li>
                    üíä <strong>Treatment decisions:</strong> Guide escalation/de-escalation of ICU
                    care
                  </li>
                </ul>

                <p class="q-mt-md"><strong>When NOT to use:</strong></p>
                <ul class="q-ml-md">
                  <li>
                    ‚ùå <strong>Non-ICU patients:</strong> Not validated for ward/ED populations
                  </li>
                  <li>
                    ‚ùå <strong>Pediatrics:</strong> Use Pediatric SOFA (pSOFA) or PELOD score
                    instead
                  </li>
                  <li>
                    ‚ùå <strong>Single time-point prognosis:</strong> Delta SOFA more predictive than
                    baseline alone
                  </li>
                  <li>
                    ‚ùå <strong>Sole treatment guide:</strong> Must integrate with clinical judgment
                  </li>
                </ul>

                <p class="q-mt-md"><strong>Limitations:</strong></p>
                <ul class="q-ml-md">
                  <li>
                    ‚ö†Ô∏è Does NOT capture <strong>all organ systems</strong> (e.g., GI, immunologic,
                    endocrine)
                  </li>
                  <li>
                    ‚ö†Ô∏è Requires <strong>accurate laboratory data</strong> (may be delayed or
                    unavailable)
                  </li>
                  <li>
                    ‚ö†Ô∏è Confounded by <strong>chronic organ dysfunction</strong> (use baseline SOFA
                    if known)
                  </li>
                  <li>
                    ‚ö†Ô∏è GCS component unreliable in <strong>sedated patients</strong> (consider
                    sedation-free assessment)
                  </li>
                  <li>
                    ‚ö†Ô∏è <strong>Not a treatment target:</strong> Improving care ‚â† improving SOFA
                    directly
                  </li>
                </ul>
              </div>
            </q-card>
          </q-expansion-item>

          <!-- 2Ô∏è‚É£ ORGAN DYSFUNCTION PHYSIOLOGY -->
          <q-expansion-item
            icon="science"
            color="medical-mint"
            label="Physiology of Multi-Organ Dysfunction"
            class="q-mt-sm"
            header-class="bg-purple-1 text-purple-9"
          >
            <q-card flat class="q-pa-md bg-purple-1">
              <div class="text-body2">
                <p class="text-weight-bold text-h6 q-mb-sm">Pathophysiological Mechanisms</p>

                <div class="q-mb-md">
                  <p class="text-weight-bold">1Ô∏è‚É£ Respiration (PaO‚ÇÇ/FiO‚ÇÇ ratio):</p>
                  <ul class="q-ml-md">
                    <li><strong>Normal P/F ratio:</strong> ‚â•400 mmHg (intact gas exchange)</li>
                    <li>
                      <strong>Hypoxemia mechanisms:</strong> V/Q mismatch, shunt, diffusion
                      impairment, hypoventilation
                    </li>
                    <li>
                      <strong>ARDS pathophysiology:</strong> Alveolar-capillary membrane damage ‚Üí
                      pulmonary edema ‚Üí surfactant dysfunction
                    </li>
                    <li>
                      <strong>Berlin ARDS criteria:</strong> Mild P/F 200-300, Moderate 100-200,
                      Severe &lt; 100
                    </li>
                    <li>
                      <strong>Critical threshold:</strong> P/F &lt;100 with respiratory support =
                      SOFA 4 (profound ARDS, mortality >40%)
                    </li>
                  </ul>
                </div>

                <div class="q-mb-md">
                  <p class="text-weight-bold">2Ô∏è‚É£ Coagulation (Platelets):</p>
                  <ul class="q-ml-md">
                    <li><strong>Normal platelets:</strong> 150-400 √ó10¬≥/ŒºL</li>
                    <li>
                      <strong>Thrombocytopenia causes in ICU:</strong> Consumptive coagulopathy
                      (DIC), bone marrow suppression, dilutional, immune-mediated (HIT)
                    </li>
                    <li>
                      <strong>DIC mechanisms:</strong> Systemic activation coagulation cascade ‚Üí
                      microthrombi ‚Üí consumption clotting factors/platelets ‚Üí bleeding + thrombosis
                    </li>
                    <li>
                      <strong>Bleeding risk:</strong> Platelets &lt; 50K significant spontaneous
                      bleeding risk, &lt;20K critical (SOFA 4)
                    </li>
                    <li>
                      <strong>Sepsis-associated:</strong> Thrombocytopenia in 30-50% septic
                      patients, marker of severity
                    </li>
                  </ul>
                </div>

                <div class="q-mb-md">
                  <p class="text-weight-bold">3Ô∏è‚É£ Liver (Bilirubin):</p>
                  <ul class="q-ml-md">
                    <li><strong>Normal bilirubin:</strong> &lt;1.2 mg/dL</li>
                    <li>
                      <strong>Hyperbilirubinemia mechanisms:</strong> Hypoxic hepatitis,
                      cholestasis, impaired conjugation/excretion
                    </li>
                    <li>
                      <strong>Shock liver:</strong> Acute ischemic injury (Zone 3 centrilobular
                      necrosis) ‚Üí transaminase ‚Üë‚Üë (>1000 IU/L) + bilirubin ‚Üë
                    </li>
                    <li>
                      <strong>Cholestasis:</strong> Sepsis-induced impaired bile flow ‚Üí conjugated
                      hyperbilirubinemia
                    </li>
                    <li>
                      <strong>Hepatic failure:</strong> Bilirubin ‚â•12 mg/dL (SOFA 4) with
                      coagulopathy/encephalopathy = poor prognosis
                    </li>
                  </ul>
                </div>

                <div class="q-mb-md">
                  <p class="text-weight-bold">4Ô∏è‚É£ Cardiovascular (MAP/Vasopressors):</p>
                  <ul class="q-ml-md">
                    <li><strong>Normal MAP:</strong> ‚â•70 mmHg (adequate tissue perfusion)</li>
                    <li>
                      <strong>Shock types:</strong> Distributive (septic), cardiogenic, hypovolemic,
                      obstructive
                    </li>
                    <li>
                      <strong>Septic shock pathophysiology:</strong> Vasodilation (NO, cytokines) +
                      myocardial depression + capillary leak ‚Üí hypotension + ‚Üìtissue O‚ÇÇ delivery
                    </li>
                    <li>
                      <strong>Vasopressor ladder:</strong> Norepinephrine 1st-line ‚Üí +Vasopressin ‚Üí
                      +Epinephrine ‚Üí High-dose (SOFA 4 = refractory shock)
                    </li>
                    <li>
                      <strong>Critical threshold:</strong> MAP &lt;65 mmHg or high-dose vasopressors
                      = end-organ hypoperfusion risk
                    </li>
                  </ul>
                </div>

                <div class="q-mb-md">
                  <p class="text-weight-bold">5Ô∏è‚É£ Central Nervous System (GCS):</p>
                  <ul class="q-ml-md">
                    <li><strong>Normal consciousness:</strong> GCS 15 (fully awake, oriented)</li>
                    <li>
                      <strong>Encephalopathy mechanisms:</strong> Hypoxia, hypoperfusion, uremic
                      toxins, hepatic encephalopathy, sepsis-associated delirium
                    </li>
                    <li>
                      <strong>Sedation confounding:</strong> GCS unreliable in sedated patients
                      (consider sedation-free assessment or exclude from SOFA)
                    </li>
                    <li>
                      <strong>Coma (GCS &lt;6):</strong> SOFA 4 = profound CNS dysfunction, high
                      mortality unless reversible cause
                    </li>
                  </ul>
                </div>

                <div class="q-mb-md">
                  <p class="text-weight-bold">6Ô∏è‚É£ Renal (Creatinine/Urine Output):</p>
                  <ul class="q-ml-md">
                    <li>
                      <strong>Normal creatinine:</strong> 0.6-1.2 mg/dL (varies by muscle mass, age,
                      sex)
                    </li>
                    <li>
                      <strong>AKI mechanisms:</strong> Pre-renal (hypoperfusion), intrinsic renal
                      (ATN, GN), post-renal (obstruction)
                    </li>
                    <li>
                      <strong>Septic AKI:</strong> Hemodynamic (hypotension) + inflammatory
                      (cytokine-mediated tubular injury) + microvascular dysfunction
                    </li>
                    <li>
                      <strong>KDIGO AKI stages:</strong> Stage 1 (Cr 1.5-1.9√ó baseline), Stage 2
                      (2.0-2.9√ó), Stage 3 (‚â•3√ó or ‚â•4 mg/dL or RRT)
                    </li>
                    <li>
                      <strong>Oliguria/anuria:</strong> &lt;500 mL/day (SOFA 3), &lt;200 mL/day
                      (SOFA 4) = severe AKI, likely RRT need
                    </li>
                  </ul>
                </div>
              </div>
            </q-card>
          </q-expansion-item>

          <!-- 3Ô∏è‚É£ HOW TO CALCULATE SOFA SCORE -->
          <q-expansion-item
            icon="calculate"
            color="medical-mint"
            label="How to Calculate SOFA Score"
            class="q-mt-sm"
            header-class="bg-green-1 text-green-9"
          >
            <q-card flat class="q-pa-md bg-green-1">
              <div class="text-body2">
                <p class="text-weight-bold text-h6 q-mb-sm">Calculation Steps</p>

                <p><strong>Step 1: Collect Worst Values (24h window)</strong></p>
                <ul class="q-ml-md q-mb-md">
                  <li>
                    üìä Use <strong>worst value</strong> for each parameter in the past 24 hours
                  </li>
                  <li>‚è∞ For serial SOFA: same time each day (e.g., 08:00 AM rounds)</li>
                  <li>üîç Ensure recent lab data: PaO‚ÇÇ, FiO‚ÇÇ, platelets, bilirubin, creatinine</li>
                  <li>
                    üíä Document MAP and any vasopressor doses (norepinephrine, dopamine,
                    epinephrine)
                  </li>
                  <li>üß† Assess GCS without sedation if possible (or note sedation influence)</li>
                  <li>üíß Calculate 24h urine output (total mL/24h)</li>
                </ul>

                <p><strong>Step 2: Score Each Organ (0-4 points)</strong></p>
                <ul class="q-ml-md q-mb-md">
                  <li><strong>Respiration:</strong> Calculate PaO‚ÇÇ/FiO‚ÇÇ ratio ‚Üí Score 0-4</li>
                  <li><strong>Coagulation:</strong> Platelets count √ó10¬≥/ŒºL ‚Üí Score 0-4</li>
                  <li><strong>Liver:</strong> Bilirubin mg/dL ‚Üí Score 0-4</li>
                  <li><strong>Cardiovascular:</strong> MAP and/or vasopressor doses ‚Üí Score 0-4</li>
                  <li><strong>CNS:</strong> Best GCS in 24h ‚Üí Score 0-4</li>
                  <li>
                    <strong>Renal:</strong> Creatinine mg/dL OR urine output ‚Üí Score 0-4 (use worse)
                  </li>
                </ul>

                <p><strong>Step 3: Sum All 6 Organ Scores</strong></p>
                <ul class="q-ml-md q-mb-md">
                  <li>
                    üßÆ <strong>Total SOFA Score</strong> = Respiration + Coagulation + Liver +
                    Cardiovascular + CNS + Renal
                  </li>
                  <li>üìà <strong>Range:</strong> 0-24 points (minimum 0, maximum 24)</li>
                  <li>
                    üìù <strong>Documentation:</strong> Record individual organ scores + total (e.g.,
                    "SOFA 12: R3 C2 L1 CV4 CNS1 Re1")
                  </li>
                </ul>

                <p><strong>Step 4: Calculate Delta SOFA (if serial measurements)</strong></p>
                <ul class="q-ml-md q-mb-md">
                  <li>Œî<strong>SOFA</strong> = SOFA(current) - SOFA(baseline or previous)</li>
                  <li>
                    üìä <strong>Interpretation:</strong> ŒîSOFA ‚â•+2 points = significant deterioration
                    (10% ‚Üë mortality per point)
                  </li>
                  <li>
                    üìâ <strong>Improvement:</strong> ŒîSOFA negative = organ function recovery
                    (favorable prognosis)
                  </li>
                  <li>
                    ü¶† <strong>Sepsis-3 definition:</strong> Infection + ŒîSOFA ‚â•2 = Sepsis (organ
                    dysfunction)
                  </li>
                </ul>

                <q-separator class="q-my-md" />

                <p class="text-weight-bold text-h6 q-mb-sm">Special Considerations</p>

                <div class="q-mb-md">
                  <p class="text-weight-bold">ü´Å Respiration (PaO‚ÇÇ/FiO‚ÇÇ):</p>
                  <ul class="q-ml-md">
                    <li>
                      <strong>Calculate P/F ratio:</strong> PaO‚ÇÇ (mmHg) / FiO‚ÇÇ (decimal, e.g., 0.40
                      for 40% oxygen)
                    </li>
                    <li>
                      <strong>Example:</strong> PaO‚ÇÇ 80 mmHg on FiO‚ÇÇ 0.50 ‚Üí P/F = 80/0.50 = 160 ‚Üí
                      SOFA 3
                    </li>
                    <li>
                      <strong>Respiratory support:</strong> Score 3-4 require ventilatory support
                      (mechanical ventilation, CPAP, high-flow)
                    </li>
                    <li>
                      <strong>If no ABG:</strong> Use SpO‚ÇÇ/FiO‚ÇÇ ratio as surrogate (less accurate)
                    </li>
                  </ul>
                </div>

                <div class="q-mb-md">
                  <p class="text-weight-bold">üíä Cardiovascular (Vasopressors):</p>
                  <ul class="q-ml-md">
                    <li>
                      <strong>Doses in Œºg/kg/min:</strong> Dopamine, dobutamine, epinephrine,
                      norepinephrine
                    </li>
                    <li><strong>Duration:</strong> Administered for ‚â•1 hour to count</li>
                    <li>
                      <strong>Combination:</strong> If multiple vasopressors ‚Üí use highest scoring
                      agent
                    </li>
                    <li>
                      <strong>MAP without vasopressors:</strong> If MAP &lt;70 mmHg without drugs ‚Üí
                      SOFA 1
                    </li>
                  </ul>
                </div>

                <div class="q-mb-md">
                  <p class="text-weight-bold">üß† CNS (Glasgow Coma Scale):</p>
                  <ul class="q-ml-md">
                    <li>
                      <strong>Best GCS in 24h:</strong> Use highest GCS observed (avoid sedation
                      periods if possible)
                    </li>
                    <li>
                      <strong>Sedation influence:</strong> If heavily sedated entire 24h ‚Üí consider
                      excluding CNS from SOFA or note limitation
                    </li>
                    <li>
                      <strong>Intubated patients:</strong> Cannot assess verbal component ‚Üí use E +
                      M only (max GCS 10)
                    </li>
                  </ul>
                </div>

                <div class="q-mb-md">
                  <p class="text-weight-bold">üíß Renal (Creatinine OR Urine Output):</p>
                  <ul class="q-ml-md">
                    <li>
                      <strong>Use WORSE of two:</strong> Creatinine mg/dL OR urine output mL/day
                    </li>
                    <li>
                      <strong>Baseline creatinine:</strong> If chronic kidney disease known ‚Üí adjust
                      interpretation (use ŒîSOFA renal)
                    </li>
                    <li>
                      <strong>RRT patients:</strong> On dialysis ‚Üí automatically SOFA 4 for renal
                    </li>
                  </ul>
                </div>
              </div>
            </q-card>
          </q-expansion-item>

          <!-- 4Ô∏è‚É£ FORMULA AND SCORING TABLES -->
          <q-expansion-item
            icon="functions"
            color="medical-mint"
            label="Formula and Scoring Tables"
            class="q-mt-sm"
            header-class="bg-cyan-1 text-cyan-9"
          >
            <q-card flat class="q-pa-md bg-cyan-1">
              <div class="text-body2">
                <p class="text-weight-bold text-h6 q-mb-sm text-center">SOFA Score Formula</p>
                <p class="text-center text-h5 q-mb-md">
                  <strong
                    >SOFA = Respiration + Coagulation + Liver + Cardiovascular + CNS + Renal</strong
                  >
                </p>
                <p class="text-center text-grey-7 q-mb-lg">
                  Each organ scored 0-4 points ‚Üí Total range 0-24 points
                </p>

                <q-separator class="q-my-md" />

                <p class="text-weight-bold text-h6 q-mb-sm">Detailed Scoring Tables</p>

                <!-- Respiration Table -->
                <div class="q-mb-md">
                  <p class="text-weight-bold">ü´Å Respiration (PaO‚ÇÇ/FiO‚ÇÇ mmHg):</p>
                  <q-markup-table dense flat bordered>
                    <thead>
                      <tr>
                        <th>Score</th>
                        <th>PaO‚ÇÇ/FiO‚ÇÇ Ratio</th>
                        <th>Clinical Interpretation</th>
                      </tr>
                    </thead>
                    <tbody>
                      <tr>
                        <td><strong>0</strong></td>
                        <td>‚â•400</td>
                        <td>Normal oxygenation</td>
                      </tr>
                      <tr>
                        <td><strong>1</strong></td>
                        <td>&lt;400</td>
                        <td>Mild hypoxemia</td>
                      </tr>
                      <tr>
                        <td><strong>2</strong></td>
                        <td>&lt;300</td>
                        <td>Moderate hypoxemia (Mild ARDS)</td>
                      </tr>
                      <tr>
                        <td><strong>3</strong></td>
                        <td>&lt;200 + ventilation</td>
                        <td>Severe hypoxemia (Moderate ARDS)</td>
                      </tr>
                      <tr>
                        <td><strong>4</strong></td>
                        <td>&lt;100 + ventilation</td>
                        <td>Profound ARDS (Severe)</td>
                      </tr>
                    </tbody>
                  </q-markup-table>
                </div>

                <!-- Coagulation Table -->
                <div class="q-mb-md">
                  <p class="text-weight-bold">ü©∏ Coagulation (Platelets √ó10¬≥/ŒºL):</p>
                  <q-markup-table dense flat bordered>
                    <thead>
                      <tr>
                        <th>Score</th>
                        <th>Platelet Count</th>
                        <th>Clinical Interpretation</th>
                      </tr>
                    </thead>
                    <tbody>
                      <tr>
                        <td><strong>0</strong></td>
                        <td>‚â•150</td>
                        <td>Normal coagulation</td>
                      </tr>
                      <tr>
                        <td><strong>1</strong></td>
                        <td>&lt;150</td>
                        <td>Mild thrombocytopenia</td>
                      </tr>
                      <tr>
                        <td><strong>2</strong></td>
                        <td>&lt;100</td>
                        <td>Moderate thrombocytopenia</td>
                      </tr>
                      <tr>
                        <td><strong>3</strong></td>
                        <td>&lt;50</td>
                        <td>Severe (bleeding risk)</td>
                      </tr>
                      <tr>
                        <td><strong>4</strong></td>
                        <td>&lt;20</td>
                        <td>Critical (spontaneous bleeding)</td>
                      </tr>
                    </tbody>
                  </q-markup-table>
                </div>

                <!-- Liver Table -->
                <div class="q-mb-md">
                  <p class="text-weight-bold">üü° Liver (Bilirubin mg/dL):</p>
                  <q-markup-table dense flat bordered>
                    <thead>
                      <tr>
                        <th>Score</th>
                        <th>Bilirubin</th>
                        <th>Clinical Interpretation</th>
                      </tr>
                    </thead>
                    <tbody>
                      <tr>
                        <td><strong>0</strong></td>
                        <td>&lt;1.2</td>
                        <td>Normal liver function</td>
                      </tr>
                      <tr>
                        <td><strong>1</strong></td>
                        <td>1.2-1.9</td>
                        <td>Mild hyperbilirubinemia</td>
                      </tr>
                      <tr>
                        <td><strong>2</strong></td>
                        <td>2.0-5.9</td>
                        <td>Moderate jaundice</td>
                      </tr>
                      <tr>
                        <td><strong>3</strong></td>
                        <td>6.0-11.9</td>
                        <td>Severe hepatic dysfunction</td>
                      </tr>
                      <tr>
                        <td><strong>4</strong></td>
                        <td>‚â•12.0</td>
                        <td>Hepatic failure</td>
                      </tr>
                    </tbody>
                  </q-markup-table>
                </div>

                <!-- Cardiovascular Table -->
                <div class="q-mb-md">
                  <p class="text-weight-bold">‚ù§Ô∏è Cardiovascular (MAP/Vasopressors):</p>
                  <q-markup-table dense flat bordered>
                    <thead>
                      <tr>
                        <th>Score</th>
                        <th>MAP or Vasopressor Doses</th>
                      </tr>
                    </thead>
                    <tbody>
                      <tr>
                        <td><strong>0</strong></td>
                        <td>MAP ‚â•70 mmHg</td>
                      </tr>
                      <tr>
                        <td><strong>1</strong></td>
                        <td>MAP &lt;70 mmHg</td>
                      </tr>
                      <tr>
                        <td><strong>2</strong></td>
                        <td>Dopamine ‚â§5 OR Dobutamine (any)</td>
                      </tr>
                      <tr>
                        <td><strong>3</strong></td>
                        <td>Dopamine >5 OR Epi ‚â§0.1 OR Norepi ‚â§0.1 (Œºg/kg/min)</td>
                      </tr>
                      <tr>
                        <td><strong>4</strong></td>
                        <td>Dopamine >15 OR Epi >0.1 OR Norepi >0.1 (Œºg/kg/min)</td>
                      </tr>
                    </tbody>
                  </q-markup-table>
                </div>

                <!-- CNS Table -->
                <div class="q-mb-md">
                  <p class="text-weight-bold">üß† CNS (Glasgow Coma Scale):</p>
                  <q-markup-table dense flat bordered>
                    <thead>
                      <tr>
                        <th>Score</th>
                        <th>GCS</th>
                        <th>Clinical Interpretation</th>
                      </tr>
                    </thead>
                    <tbody>
                      <tr>
                        <td><strong>0</strong></td>
                        <td>15</td>
                        <td>Fully awake and oriented</td>
                      </tr>
                      <tr>
                        <td><strong>1</strong></td>
                        <td>13-14</td>
                        <td>Mild altered mental status</td>
                      </tr>
                      <tr>
                        <td><strong>2</strong></td>
                        <td>10-12</td>
                        <td>Moderate confusion/drowsiness</td>
                      </tr>
                      <tr>
                        <td><strong>3</strong></td>
                        <td>6-9</td>
                        <td>Severe coma (localizes pain)</td>
                      </tr>
                      <tr>
                        <td><strong>4</strong></td>
                        <td>&lt;6</td>
                        <td>Deep coma (no response)</td>
                      </tr>
                    </tbody>
                  </q-markup-table>
                </div>

                <!-- Renal Table -->
                <div class="q-mb-md">
                  <p class="text-weight-bold">üíß Renal (Creatinine mg/dL OR Urine Output):</p>
                  <q-markup-table dense flat bordered>
                    <thead>
                      <tr>
                        <th>Score</th>
                        <th>Creatinine OR Urine Output</th>
                      </tr>
                    </thead>
                    <tbody>
                      <tr>
                        <td><strong>0</strong></td>
                        <td>&lt;1.2 mg/dL</td>
                      </tr>
                      <tr>
                        <td><strong>1</strong></td>
                        <td>1.2-1.9 mg/dL</td>
                      </tr>
                      <tr>
                        <td><strong>2</strong></td>
                        <td>2.0-3.4 mg/dL</td>
                      </tr>
                      <tr>
                        <td><strong>3</strong></td>
                        <td>3.5-4.9 mg/dL OR &lt;500 mL/day</td>
                      </tr>
                      <tr>
                        <td><strong>4</strong></td>
                        <td>‚â•5.0 mg/dL OR &lt;200 mL/day OR RRT</td>
                      </tr>
                    </tbody>
                  </q-markup-table>
                </div>

                <q-separator class="q-my-md" />

                <p class="text-weight-bold text-h6 q-mb-sm">Delta SOFA (ŒîSOFA) Calculation</p>
                <p class="text-center q-mb-sm">
                  <strong>ŒîSOFA = SOFA(current) - SOFA(baseline)</strong>
                </p>
                <ul class="q-ml-md">
                  <li>
                    <strong>Baseline:</strong> First SOFA score on ICU admission OR pre-illness
                    baseline if known
                  </li>
                  <li>
                    <strong>ŒîSOFA ‚â•+2:</strong> Sepsis criterion (Sepsis-3 definition), 10%
                    increased mortality per point
                  </li>
                  <li>
                    <strong>ŒîSOFA negative:</strong> Improving organ function (favorable trajectory)
                  </li>
                  <li>
                    <strong>ŒîSOFA +3-4:</strong> Significant clinical deterioration, reassess
                    treatment
                  </li>
                </ul>
              </div>
            </q-card>
          </q-expansion-item>

          <!-- 5Ô∏è‚É£ CLINICAL INTERPRETATION -->
          <q-expansion-item
            icon="psychology"
            color="medical-mint"
            label="Clinical Interpretation and Mortality Prediction"
            class="q-mt-sm"
            header-class="bg-orange-1 text-orange-9"
          >
            <q-card flat class="q-pa-md bg-orange-1">
              <div class="text-body2">
                <p class="text-weight-bold text-h6 q-mb-sm">Mortality Risk Stratification</p>

                <div class="q-mb-md">
                  <q-chip color="green" text-color="white" dense class="q-mb-xs">
                    <q-icon name="check_circle" class="q-mr-xs" />
                    SOFA 0-6: Low Risk
                  </q-chip>
                  <p>
                    <strong>Mortality risk:</strong> &lt;10-15% in-hospital mortality<br />
                    <strong>Clinical status:</strong> Mild organ dysfunction or single organ
                    involvement<br />
                    <strong>ICU course:</strong> Typically shorter ICU stay, good recovery
                    potential<br />
                    <strong>Management:</strong> Standard ICU care, monitor for deterioration
                  </p>
                </div>

                <div class="q-mb-md">
                  <q-chip color="orange" text-color="white" dense class="q-mb-xs">
                    <q-icon name="warning" class="q-mr-xs" />
                    SOFA 7-9: Moderate Risk
                  </q-chip>
                  <p>
                    <strong>Mortality risk:</strong> 15-20% in-hospital mortality<br />
                    <strong>Clinical status:</strong> Moderate multi-organ dysfunction<br />
                    <strong>ICU course:</strong> Prolonged ICU stay likely, requires close
                    monitoring<br />
                    <strong>Management:</strong> Aggressive organ support, daily SOFA trending
                  </p>
                </div>

                <div class="q-mb-md">
                  <q-chip color="red" text-color="white" dense class="q-mb-xs">
                    <q-icon name="dangerous" class="q-mr-xs" />
                    SOFA 10-12: High Risk
                  </q-chip>
                  <p>
                    <strong>Mortality risk:</strong> 40-50% in-hospital mortality<br />
                    <strong>Clinical status:</strong> Severe multi-organ failure<br />
                    <strong>ICU course:</strong> Very prolonged ICU stay, complex management<br />
                    <strong>Management:</strong> Maximum organ support, consider advanced therapies
                    (ECMO, RRT, etc.)
                  </p>
                </div>

                <div class="q-mb-md">
                  <q-chip color="red-10" text-color="white" dense class="q-mb-xs">
                    <q-icon name="local_hospital" class="q-mr-xs" />
                    SOFA 13-14: Very High Risk
                  </q-chip>
                  <p>
                    <strong>Mortality risk:</strong> 50-95% in-hospital mortality<br />
                    <strong>Clinical status:</strong> Profound multiple organ failure<br />
                    <strong>ICU course:</strong> Salvage therapy, extremely poor prognosis<br />
                    <strong>Management:</strong> Maximum ICU resources, family discussions about
                    goals of care
                  </p>
                </div>

                <div class="q-mb-lg">
                  <q-chip color="red-10" text-color="white" dense class="q-mb-xs">
                    <q-icon name="report" class="q-mr-xs" />
                    SOFA ‚â•15: Catastrophic
                  </q-chip>
                  <p>
                    <strong>Mortality risk:</strong> >90% in-hospital mortality<br />
                    <strong>Clinical status:</strong> Multi-organ failure with extremely poor
                    prognosis<br />
                    <strong>ICU course:</strong> Survival extremely rare<br />
                    <strong>Management:</strong> Palliative care discussions appropriate, withdrawal
                    of care may be considered
                  </p>
                </div>

                <q-separator class="q-my-md" />

                <p class="text-weight-bold text-h6 q-mb-sm">Delta SOFA (ŒîSOFA) Interpretation</p>

                <ul class="q-ml-md">
                  <li>
                    <strong>ŒîSOFA +1 point:</strong> ~10% increased mortality risk per point
                    increase
                  </li>
                  <li>
                    <strong>ŒîSOFA ‚â•+2 points (within 48h):</strong> Sepsis-3 criterion for organ
                    dysfunction. Significant clinical deterioration. Triggers sepsis bundle
                    protocols (antibiotics, fluid resuscitation, source control).
                  </li>
                  <li>
                    <strong>ŒîSOFA +3-4 points:</strong> Severe deterioration, reassess diagnosis and
                    treatment. Consider missed infection source, resistant organisms, complications.
                  </li>
                  <li>
                    <strong>ŒîSOFA negative (decreasing):</strong> Improving organ function,
                    favorable trajectory. Treatment effective, consider de-escalation when
                    appropriate.
                  </li>
                  <li>
                    <strong>ŒîSOFA plateau (unchanged):</strong> Static course, neither improving nor
                    worsening. May indicate chronic organ dysfunction or treatment equilibrium.
                  </li>
                </ul>

                <q-separator class="q-my-md" />

                <p class="text-weight-bold text-h6 q-mb-sm">Sepsis-3 Definition Integration</p>
                <p>
                  <strong>Sepsis (Sepsis-3):</strong> Life-threatening organ dysfunction caused by
                  dysregulated host response to infection
                </p>
                <ul class="q-ml-md">
                  <li>
                    <strong>Criteria:</strong> Suspected or documented infection +
                    <strong>ŒîSOFA ‚â•2 points</strong>
                  </li>
                  <li>
                    <strong>Baseline SOFA:</strong> Assume 0 if no pre-existing organ dysfunction
                    known
                  </li>
                  <li>
                    <strong>Septic Shock:</strong> Sepsis + vasopressor requirement (MAP ‚â•65 mmHg) +
                    lactate >2 mmol/L despite adequate fluid resuscitation
                  </li>
                  <li>
                    <strong>Mortality:</strong> Sepsis ~10%, Septic Shock ~40% in-hospital mortality
                  </li>
                </ul>

                <q-banner class="bg-orange-2 text-orange-9 q-mt-md" dense rounded>
                  <template v-slot:avatar>
                    <q-icon name="info" color="orange" />
                  </template>
                  <strong>Clinical Pearl:</strong> Serial SOFA trending (daily) is MORE predictive
                  than single baseline SOFA. Worsening ŒîSOFA indicates treatment failure or
                  complications. Improving ŒîSOFA validates treatment efficacy.
                </q-banner>
              </div>
            </q-card>
          </q-expansion-item>

          <!-- 6Ô∏è‚É£ CLINICAL APPLICATIONS -->
          <q-expansion-item
            icon="medical_services"
            color="medical-mint"
            label="Clinical Applications of SOFA Score"
            class="q-mt-sm"
            header-class="bg-teal-1 text-teal-9"
          >
            <q-card flat class="q-pa-md bg-teal-1">
              <div class="text-body2">
                <p class="text-weight-bold text-h6 q-mb-sm">Primary Clinical Uses</p>

                <div class="q-mb-md">
                  <p class="text-weight-bold">
                    1Ô∏è‚É£ Sepsis Diagnosis and Severity Stratification (Sepsis-3)
                  </p>
                  <ul class="q-ml-md">
                    <li>
                      <strong>Screening:</strong> qSOFA (quick SOFA) ‚â•2 ‚Üí triggers full SOFA
                      calculation
                    </li>
                    <li>
                      <strong>Diagnosis:</strong> Infection + ŒîSOFA ‚â•2 = Sepsis (organ dysfunction)
                    </li>
                    <li>
                      <strong>Severity:</strong> Baseline SOFA 0-6 (less severe), 7-12 (moderate),
                      ‚â•13 (severe)
                    </li>
                    <li>
                      <strong>Septic shock:</strong> Sepsis + vasopressors + lactate >2 mmol/L
                    </li>
                    <li>
                      <strong>Triggers:</strong> SOFA ‚â•2 ‚Üí initiate sepsis bundles (1-hour bundle:
                      blood cultures, antibiotics, fluid resuscitation)
                    </li>
                  </ul>
                </div>

                <div class="q-mb-md">
                  <p class="text-weight-bold">2Ô∏è‚É£ ICU Admission Triage and Bed Allocation</p>
                  <ul class="q-ml-md">
                    <li>
                      <strong>Baseline SOFA >10:</strong> High-risk patient, requires intensive
                      monitoring and resources
                    </li>
                    <li>
                      <strong>Resource allocation:</strong> Prioritize ICU beds for SOFA >8 during
                      surge capacity
                    </li>
                    <li>
                      <strong>Step-down criteria:</strong> SOFA decreasing to &lt;6 with stable
                      trend ‚Üí consider ICU discharge to step-down unit
                    </li>
                    <li>
                      <strong>Prognosis discussion:</strong> SOFA ‚â•15 ‚Üí poor prognosis, discuss
                      goals of care with family
                    </li>
                  </ul>
                </div>

                <div class="q-mb-md">
                  <p class="text-weight-bold">3Ô∏è‚É£ Serial Monitoring and Deterioration Detection</p>
                  <ul class="q-ml-md">
                    <li>
                      <strong>Daily SOFA:</strong> Calculate at same time each day (e.g., morning
                      rounds 08:00)
                    </li>
                    <li>
                      <strong>Trend analysis:</strong> Graph SOFA over time to visualize trajectory
                      (improving vs worsening)
                    </li>
                    <li>
                      <strong>Alert thresholds:</strong> ŒîSOFA ‚â•+2 in 24-48h ‚Üí clinical alert,
                      reassess treatment plan
                    </li>
                    <li>
                      <strong>Organ-specific deterioration:</strong> Track individual organ scores
                      to identify failing system (e.g., renal SOFA 0‚Üí3 = new AKI)
                    </li>
                  </ul>
                </div>

                <div class="q-mb-md">
                  <p class="text-weight-bold">4Ô∏è‚É£ Clinical Trial Endpoints and Research</p>
                  <ul class="q-ml-md">
                    <li>
                      <strong>Inclusion criteria:</strong> Many sepsis trials require baseline SOFA
                      ‚â•2 or specific organ SOFA thresholds
                    </li>
                    <li>
                      <strong>Primary outcome:</strong> ŒîSOFA at day 7 or ICU discharge used as
                      efficacy endpoint
                    </li>
                    <li>
                      <strong>Stratification:</strong> Randomize by baseline SOFA categories (e.g.,
                      &lt;8 vs ‚â•8) to balance severity
                    </li>
                    <li>
                      <strong>Standardized measure:</strong> Allows comparison across international
                      studies and institutions
                    </li>
                  </ul>
                </div>

                <div class="q-mb-md">
                  <p class="text-weight-bold">5Ô∏è‚É£ Prognostic Communication with Families</p>
                  <ul class="q-ml-md">
                    <li>
                      <strong>Baseline SOFA 8-12:</strong> "Your family member has moderate organ
                      dysfunction, 15-50% mortality risk, prolonged ICU stay expected"
                    </li>
                    <li>
                      <strong>SOFA ‚â•15:</strong> "Catastrophic multi-organ failure, >90% mortality,
                      palliative care discussions appropriate"
                    </li>
                    <li>
                      <strong>Improving ŒîSOFA:</strong> "Organ function recovering, treatment
                      effective, favorable prognosis"
                    </li>
                    <li>
                      <strong>Worsening ŒîSOFA:</strong> "Condition deteriorating despite treatment,
                      need to reassess goals of care"
                    </li>
                  </ul>
                </div>

                <div class="q-mb-lg">
                  <p class="text-weight-bold">6Ô∏è‚É£ Quality Metrics and ICU Performance</p>
                  <ul class="q-ml-md">
                    <li>
                      <strong>Severity-adjusted mortality:</strong> Compare observed vs predicted
                      mortality (Standardized Mortality Ratio)
                    </li>
                    <li>
                      <strong>ICU benchmarking:</strong> SOFA used in APACHE IV, SAPS 3 models for
                      severity adjustment
                    </li>
                    <li>
                      <strong>Length of stay prediction:</strong> Baseline SOFA correlates with ICU
                      LOS and mechanical ventilation days
                    </li>
                    <li>
                      <strong>Risk stratification:</strong> Report outcomes stratified by SOFA
                      categories for quality improvement
                    </li>
                  </ul>
                </div>

                <q-separator class="q-my-md" />

                <p class="text-weight-bold text-h6 q-mb-sm">qSOFA (quick SOFA) Screening Tool</p>
                <p>
                  <strong>Purpose:</strong> Rapid bedside screening for sepsis risk (ED, ward,
                  pre-hospital)
                </p>
                <ul class="q-ml-md">
                  <li>
                    <strong>Criteria (1 point each):</strong> (1) Respiratory rate ‚â•22/min, (2)
                    Altered mental status (GCS &lt;15), (3) Systolic BP ‚â§100 mmHg
                  </li>
                  <li>
                    <strong>qSOFA ‚â•2:</strong> Positive screen ‚Üí calculate full SOFA score, initiate
                    sepsis workup
                  </li>
                  <li>
                    <strong>Advantages:</strong> No lab tests required, fast bedside assessment (1
                    minute)
                  </li>
                  <li>
                    <strong>Limitations:</strong> Lower sensitivity than full SOFA (more false
                    negatives), not for diagnosis (screening only)
                  </li>
                </ul>
              </div>
            </q-card>
          </q-expansion-item>

          <!-- 7Ô∏è‚É£ REFERENCE VALUES AND ALERTS -->
          <q-expansion-item
            icon="warning"
            color="medical-mint"
            label="Reference Values and Critical Alerts"
            class="q-mt-sm"
            header-class="bg-red-1 text-red-9"
          >
            <q-card flat class="q-pa-md bg-red-1">
              <div class="text-body2">
                <p class="text-weight-bold text-h6 q-mb-sm">Organ-Specific Critical Thresholds</p>

                <div class="q-mb-md">
                  <p class="text-weight-bold">ü´Å Respiration:</p>
                  <ul class="q-ml-md">
                    <li>
                      <strong>Normal P/F ratio:</strong> ‚â•400 mmHg (room air or minimal supplemental
                      O‚ÇÇ)
                    </li>
                    <li><strong>Mild ARDS:</strong> P/F 200-300 (SOFA 2, moderate hypoxemia)</li>
                    <li>
                      <strong>Moderate ARDS:</strong> P/F 100-200 (SOFA 3, severe hypoxemia,
                      requires ventilation)
                    </li>
                    <li>
                      <strong>Severe ARDS:</strong> P/F &lt;100 (SOFA 4, refractory hypoxemia,
                      consider ECMO, proning, recruitment maneuvers)
                    </li>
                    <li>
                      <strong>‚ö†Ô∏è ALERT:</strong> P/F &lt;100 despite optimal ventilation ‚Üí rescue
                      therapies (ECMO, prone positioning, inhaled NO)
                    </li>
                  </ul>
                </div>

                <div class="q-mb-md">
                  <p class="text-weight-bold">ü©∏ Coagulation:</p>
                  <ul class="q-ml-md">
                    <li><strong>Normal platelets:</strong> 150-400 √ó10¬≥/ŒºL</li>
                    <li>
                      <strong>Moderate thrombocytopenia:</strong> 50-100K (SOFA 2-3, monitor
                      bleeding risk)
                    </li>
                    <li>
                      <strong>Severe thrombocytopenia:</strong> &lt;50K (SOFA 3, prophylactic
                      platelet transfusion if procedures/bleeding)
                    </li>
                    <li>
                      <strong>Critical thrombocytopenia:</strong> &lt;20K (SOFA 4, spontaneous
                      bleeding risk, urgent platelet transfusion)
                    </li>
                    <li>
                      <strong>‚ö†Ô∏è ALERT:</strong> Platelets &lt;20K + active bleeding ‚Üí emergent
                      transfusion, consider DIC workup (PT/PTT, fibrinogen, D-dimer)
                    </li>
                  </ul>
                </div>

                <div class="q-mb-md">
                  <p class="text-weight-bold">üü° Liver:</p>
                  <ul class="q-ml-md">
                    <li><strong>Normal bilirubin:</strong> &lt;1.2 mg/dL</li>
                    <li>
                      <strong>Moderate hyperbilirubinemia:</strong> 2-6 mg/dL (SOFA 2, jaundice
                      visible)
                    </li>
                    <li>
                      <strong>Severe hepatic dysfunction:</strong> 6-12 mg/dL (SOFA 3, consider
                      hepatic encephalopathy risk)
                    </li>
                    <li>
                      <strong>Hepatic failure:</strong> ‚â•12 mg/dL (SOFA 4, check coagulation,
                      ammonia, consider liver transplant evaluation)
                    </li>
                    <li>
                      <strong>‚ö†Ô∏è ALERT:</strong> Bilirubin ‚â•12 + INR >2.0 + encephalopathy ‚Üí acute
                      liver failure, hepatology consult urgent
                    </li>
                  </ul>
                </div>

                <div class="q-mb-md">
                  <p class="text-weight-bold">‚ù§Ô∏è Cardiovascular:</p>
                  <ul class="q-ml-md">
                    <li><strong>Normal MAP:</strong> ‚â•70 mmHg without vasopressors</li>
                    <li>
                      <strong>Hypotension:</strong> MAP &lt;70 mmHg (SOFA 1, fluid resuscitation)
                    </li>
                    <li>
                      <strong>Low-dose vasopressors:</strong> Dopamine ‚â§5 or dobutamine (SOFA 2)
                    </li>
                    <li>
                      <strong>Moderate vasopressors:</strong> Dopamine >5 or low-dose epi/norepi
                      (SOFA 3, septic shock)
                    </li>
                    <li>
                      <strong>High-dose vasopressors:</strong> Dopamine >15 or high-dose epi/norepi
                      (SOFA 4, refractory shock)
                    </li>
                    <li>
                      <strong>‚ö†Ô∏è ALERT:</strong> SOFA CV 4 (refractory shock) ‚Üí exclude tamponade,
                      tension pneumothorax, PE, consider ECMO, stress-dose steroids
                    </li>
                  </ul>
                </div>

                <div class="q-mb-md">
                  <p class="text-weight-bold">üß† CNS:</p>
                  <ul class="q-ml-md">
                    <li><strong>Normal consciousness:</strong> GCS 15 (fully awake)</li>
                    <li><strong>Mild AMS:</strong> GCS 13-14 (SOFA 1, confusion/disorientation)</li>
                    <li><strong>Moderate AMS:</strong> GCS 10-12 (SOFA 2, drowsy but arousable)</li>
                    <li>
                      <strong>Severe coma:</strong> GCS 6-9 (SOFA 3, localizes pain, consider
                      intubation for airway protection)
                    </li>
                    <li>
                      <strong>Deep coma:</strong> GCS &lt;6 (SOFA 4, no response, poor prognosis)
                    </li>
                    <li>
                      <strong>‚ö†Ô∏è ALERT:</strong> GCS &lt;6 + fixed dilated pupils ‚Üí brain death
                      evaluation, CT head urgent
                    </li>
                  </ul>
                </div>

                <div class="q-mb-md">
                  <p class="text-weight-bold">üíß Renal:</p>
                  <ul class="q-ml-md">
                    <li>
                      <strong>Normal creatinine:</strong> 0.6-1.2 mg/dL (varies by age/sex/muscle
                      mass)
                    </li>
                    <li>
                      <strong>AKI Stage 1:</strong> Cr 1.2-1.9 (SOFA 1, monitor, optimize
                      hemodynamics)
                    </li>
                    <li>
                      <strong>AKI Stage 2:</strong> Cr 2.0-3.4 (SOFA 2, nephrology aware, avoid
                      nephrotoxins)
                    </li>
                    <li>
                      <strong>AKI Stage 3:</strong> Cr 3.5-4.9 or oliguria &lt;500 mL/day (SOFA 3,
                      consider RRT soon)
                    </li>
                    <li>
                      <strong>Renal failure:</strong> Cr ‚â•5.0 or anuria &lt;200 mL/day (SOFA 4, RRT
                      indicated)
                    </li>
                    <li>
                      <strong>‚ö†Ô∏è ALERT:</strong> SOFA Renal 4 + hyperkalemia (K+ >6.5) or pulmonary
                      edema ‚Üí emergent dialysis
                    </li>
                  </ul>
                </div>

                <q-separator class="q-my-md" />

                <p class="text-weight-bold text-h6 q-mb-sm">Critical SOFA Alert Thresholds</p>
                <q-list dense class="bg-red-2">
                  <q-item>
                    <q-item-section avatar>
                      <q-icon color="red" name="dangerous" size="sm" />
                    </q-item-section>
                    <q-item-section>
                      <q-item-label class="text-weight-bold">SOFA ‚â•15</q-item-label>
                      <q-item-label caption>
                        Catastrophic multi-organ failure. >90% mortality. Palliative care
                        discussions appropriate.
                      </q-item-label>
                    </q-item-section>
                  </q-item>
                  <q-item>
                    <q-item-section avatar>
                      <q-icon color="red" name="trending_up" size="sm" />
                    </q-item-section>
                    <q-item-section>
                      <q-item-label class="text-weight-bold">ŒîSOFA ‚â•+2 in 24-48h</q-item-label>
                      <q-item-label caption>
                        Sepsis criterion. Significant deterioration. Reassess diagnosis, treatment,
                        infection source control.
                      </q-item-label>
                    </q-item-section>
                  </q-item>
                  <q-item>
                    <q-item-section avatar>
                      <q-icon color="orange" name="warning" size="sm" />
                    </q-item-section>
                    <q-item-section>
                      <q-item-label class="text-weight-bold">Any single organ SOFA 4</q-item-label>
                      <q-item-label caption>
                        Severe single organ failure. High risk. Requires aggressive organ-specific
                        support (e.g., ECMO for respiratory SOFA 4, RRT for renal SOFA 4).
                      </q-item-label>
                    </q-item-section>
                  </q-item>
                  <q-item>
                    <q-item-section avatar>
                      <q-icon color="orange" name="speed" size="sm" />
                    </q-item-section>
                    <q-item-section>
                      <q-item-label class="text-weight-bold">SOFA 10-12</q-item-label>
                      <q-item-label caption>
                        High risk. 40-50% mortality. Very prolonged ICU course expected. Maximum
                        organ support indicated.
                      </q-item-label>
                    </q-item-section>
                  </q-item>
                </q-list>

                <q-separator class="q-my-md" />

                <p class="text-weight-bold text-h6 q-mb-sm">
                  Baseline and Chronic Organ Dysfunction
                </p>
                <ul class="q-ml-md">
                  <li>
                    <strong>Known baseline SOFA:</strong> If chronic organ dysfunction pre-illness
                    (e.g., ESRD, cirrhosis, COPD) ‚Üí use pre-illness baseline SOFA for ŒîSOFA
                    calculation
                  </li>
                  <li>
                    <strong>Dialysis patients:</strong> Renal SOFA automatically 4 (on RRT) ‚Üí focus
                    on other organ scores
                  </li>
                  <li>
                    <strong>Elderly/frail:</strong> May have higher baseline SOFA (e.g., mild renal
                    impairment Cr 1.5) ‚Üí interpret absolute SOFA with caution, ŒîSOFA more valuable
                  </li>
                  <li>
                    <strong>Pediatrics:</strong> SOFA not validated &lt;18 years ‚Üí use Pediatric
                    SOFA (pSOFA) or PELOD-2 score instead
                  </li>
                </ul>
              </div>
            </q-card>
          </q-expansion-item>

          <!-- 8Ô∏è‚É£ MEDICAL DOCUMENTATION AND GUIDELINES -->
          <q-expansion-item
            icon="menu_book"
            color="medical-mint"
            label="Medical Documentation and Guidelines"
            class="q-mt-sm"
            header-class="bg-indigo-1 text-indigo-9"
          >
            <q-card flat class="q-pa-md bg-indigo-1">
              <div class="text-body2">
                <p class="text-weight-bold text-h6 q-mb-sm">
                  International Guidelines and Consensus Definitions
                </p>

                <div class="q-mb-md">
                  <p class="text-weight-bold">üìã Sepsis-3 Consensus Definitions (2016)</p>
                  <ul class="q-ml-md">
                    <li>
                      <strong>Task Force:</strong> Society of Critical Care Medicine (SCCM) +
                      European Society of Intensive Care Medicine (ESICM)
                    </li>
                    <li>
                      <strong>Sepsis definition:</strong> Life-threatening organ dysfunction caused
                      by dysregulated host response to infection, operationalized as
                      <strong>SOFA score ‚â•2 points</strong> from baseline
                    </li>
                    <li>
                      <strong>Septic shock definition:</strong> Sepsis + vasopressor requirement to
                      maintain MAP ‚â•65 mmHg + serum lactate >2 mmol/L despite adequate fluid
                      resuscitation
                    </li>
                    <li>
                      <strong>qSOFA screening:</strong> Respiratory rate ‚â•22/min, altered mental
                      status (GCS &lt;15), systolic BP ‚â§100 mmHg (‚â•2 of 3 ‚Üí positive screen)
                    </li>
                    <li>
                      <strong>Impact:</strong> Replaced SIRS criteria (Sepsis-1/2 definitions).
                      SOFA-based definition improves prognostic accuracy and clinical relevance.
                    </li>
                  </ul>
                </div>

                <div class="q-mb-md">
                  <p class="text-weight-bold">üìã Surviving Sepsis Campaign Guidelines (2021)</p>
                  <ul class="q-ml-md">
                    <li>
                      <strong>1-Hour Bundle:</strong> Measure lactate, obtain blood cultures before
                      antibiotics, administer broad-spectrum antibiotics, begin rapid fluid
                      resuscitation (30 mL/kg crystalloid) if sepsis/septic shock suspected
                    </li>
                    <li>
                      <strong>SOFA role:</strong> Used to confirm organ dysfunction (SOFA ‚â•2 from
                      baseline) and guide treatment escalation
                    </li>
                    <li>
                      <strong>Serial monitoring:</strong> Daily SOFA scores recommended to assess
                      treatment response and guide de-escalation
                    </li>
                    <li>
                      <strong>Vasopressor guidelines:</strong> Norepinephrine first-line, target MAP
                      ‚â•65 mmHg, add vasopressin or epinephrine if refractory (aligns with SOFA
                      cardiovascular scoring)
                    </li>
                  </ul>
                </div>

                <div class="q-mb-md">
                  <p class="text-weight-bold">üìã Berlin ARDS Definition (2012)</p>
                  <ul class="q-ml-md">
                    <li>
                      <strong>Integration with SOFA:</strong> SOFA respiration component based on
                      P/F ratio aligns with Berlin ARDS severity categories
                    </li>
                    <li><strong>Mild ARDS:</strong> P/F 200-300 (SOFA respiratory 2)</li>
                    <li><strong>Moderate ARDS:</strong> P/F 100-200 (SOFA respiratory 3)</li>
                    <li><strong>Severe ARDS:</strong> P/F &lt;100 (SOFA respiratory 4)</li>
                    <li>
                      <strong>Ventilation requirement:</strong> SOFA 3-4 require respiratory support
                      (mechanical ventilation, CPAP, or high-flow nasal cannula ‚â•10 L/min)
                    </li>
                  </ul>
                </div>

                <div class="q-mb-md">
                  <p class="text-weight-bold">üìã KDIGO AKI Guidelines (2012)</p>
                  <ul class="q-ml-md">
                    <li>
                      <strong>AKI staging:</strong> Stage 1 (Cr 1.5-1.9√ó baseline), Stage 2
                      (2.0-2.9√ó), Stage 3 (‚â•3√ó or ‚â•4 mg/dL or RRT) partially aligns with SOFA renal
                      scoring
                    </li>
                    <li>
                      <strong>Urine output criteria:</strong> SOFA uses &lt;500 mL/day (SOFA 3) and
                      &lt;200 mL/day (SOFA 4), similar to KDIGO AKI UO criteria
                    </li>
                    <li>
                      <strong>RRT indication:</strong> SOFA renal 4 often indicates RRT candidacy
                      (severe AKI, oliguria/anuria)
                    </li>
                  </ul>
                </div>

                <q-separator class="q-my-md" />

                <p class="text-weight-bold text-h6 q-mb-sm">
                  Clinical Documentation Best Practices
                </p>

                <div class="q-mb-md">
                  <p class="text-weight-bold">üìù SOFA Score Documentation Template:</p>
                  <q-card flat bordered class="q-pa-sm bg-white">
                    <pre class="text-caption q-ma-none">
<strong>ICU Day 3 - SOFA Score:</strong>

<strong>Total SOFA: 12</strong> (‚Üë from Day 2 SOFA 10, ŒîSOFA +2)

<strong>Individual Organ Scores:</strong>
- Respiration: 3 (P/F ratio 180 mmHg on FiO‚ÇÇ 0.60, intubated)
- Coagulation: 2 (Platelets 95 √ó10¬≥/ŒºL, ‚Üì from 120K)
- Liver: 1 (Bilirubin 1.8 mg/dL)
- Cardiovascular: 4 (Norepinephrine 0.25 Œºg/kg/min, MAP 68 mmHg)
- CNS: 1 (GCS 14, sedation off for assessment)
- Renal: 1 (Creatinine 1.7 mg/dL, UO 1200 mL/24h)

<strong>Clinical Interpretation:</strong>
High-risk patient with severe multi-organ dysfunction.
ŒîSOFA +2 indicates deterioration despite antibiotics/fluids.

<strong>Action Plan:</strong>
1. Broaden antibiotics (add antifungal coverage)
2. Increase vasopressor support (MAP target 65-70 mmHg)
3. CT abdomen for source control evaluation
4. Family meeting to discuss prognosis (40-50% mortality risk)
5. Continue daily SOFA trending
                      </pre>
                  </q-card>
                </div>

                <div class="q-mb-md">
                  <p class="text-weight-bold">üìä Serial SOFA Trending Chart (recommend in EMR):</p>
                  <ul class="q-ml-md">
                    <li>
                      <strong>Daily total SOFA:</strong> Graph over ICU stay to visualize trajectory
                    </li>
                    <li>
                      <strong>Organ-specific trends:</strong> Track individual organ scores to
                      identify specific failures (e.g., renal SOFA 0‚Üí3 = new AKI)
                    </li>
                    <li>
                      <strong>Color-coding:</strong> Green (SOFA 0-6), Orange (7-12), Red (‚â•13) for
                      quick severity assessment
                    </li>
                    <li>
                      <strong>Annotations:</strong> Mark major interventions (e.g., "Day 2:
                      Antibiotics changed", "Day 4: Source control surgery")
                    </li>
                  </ul>
                </div>

                <q-separator class="q-my-md" />

                <p class="text-weight-bold text-h6 q-mb-sm">
                  Research and Quality Improvement Applications
                </p>

                <ul class="q-ml-md">
                  <li>
                    <strong>Clinical trial stratification:</strong> Randomize by baseline SOFA
                    (&lt;8 vs ‚â•8) to balance severity between arms
                  </li>
                  <li>
                    <strong>Primary endpoints:</strong> ŒîSOFA at day 7, SOFA-free days (days alive
                    and with SOFA &lt;6), organ failure-free days
                  </li>
                  <li>
                    <strong>Secondary endpoints:</strong> Individual organ SOFA scores (e.g.,
                    respiratory SOFA improvement in ARDS trial)
                  </li>
                  <li>
                    <strong>ICU benchmarking:</strong> Severity-adjusted outcomes using SOFA in
                    APACHE IV, SAPS 3 models
                  </li>
                  <li>
                    <strong>Quality metrics:</strong> Sepsis mortality stratified by baseline SOFA
                    for hospital quality reporting
                  </li>
                </ul>
              </div>
            </q-card>
          </q-expansion-item>

          <!-- 9Ô∏è‚É£ SCIENTIFIC REFERENCES (PMID) -->
          <q-expansion-item
            icon="import_contacts"
            color="medical-mint"
            label="Scientific References (PMID Citations)"
            class="q-mt-sm"
            header-class="bg-purple-1 text-purple-9"
          >
            <q-card flat class="q-pa-md bg-purple-1">
              <div class="text-body2">
                <p class="text-weight-bold text-h6 q-mb-sm">Key Publications and PMID Citations</p>

                <div class="q-mb-md">
                  <p class="text-weight-bold">üìÑ Vincent JL, Moreno R, Takala J, et al. (1996)</p>
                  <p class="q-ml-md text-grey-8">
                    "The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ
                    dysfunction/failure"<br />
                    <em>Intensive Care Medicine</em>, 22(7): 707-710<br />
                    <strong>PMID: 8863252</strong><br />
                    <strong>Original SOFA score publication.</strong> Developed by European Society
                    of Intensive Care Medicine working group. Validated in 1449 ICU patients.
                    Proposed 6-organ scoring system (0-4 each, total 0-24). Demonstrated correlation
                    with ICU mortality (SOFA ‚â•15 ‚Üí >90% mortality). Emphasized utility for
                    <strong>serial assessment</strong> (delta SOFA) rather than single time-point.
                  </p>
                </div>

                <div class="q-mb-md">
                  <p class="text-weight-bold">
                    üìÑ Singer M, Deutschman CS, Seymour CW, et al. (2016)
                  </p>
                  <p class="q-ml-md text-grey-8">
                    "The Third International Consensus Definitions for Sepsis and Septic Shock
                    (Sepsis-3)"<br />
                    <em>JAMA</em>, 315(8): 801-810<br />
                    <strong>PMID: 26903338</strong><br />
                    <strong>Sepsis-3 consensus definitions.</strong> SCCM + ESICM task force.
                    Redefined sepsis as "life-threatening organ dysfunction (SOFA ‚â•2 from baseline)
                    caused by dysregulated host response to infection". Replaced SIRS criteria.
                    Introduced qSOFA screening tool. Validated in 148,907 patients across 12
                    databases. SOFA ‚â•2 had <strong>superior predictive validity</strong> vs SIRS
                    (AUROC 0.74 vs 0.64 for in-hospital mortality).
                  </p>
                </div>

                <div class="q-mb-md">
                  <p class="text-weight-bold">üìÑ Ferreira FL, Bota DP, Bross A, et al. (2001)</p>
                  <p class="q-ml-md text-grey-8">
                    "Serial evaluation of the SOFA score to predict outcome in critically ill
                    patients"<br />
                    <em>JAMA</em>, 286(14): 1754-1758<br />
                    <strong>PMID: 11594901</strong><br />
                    <strong>Validation of serial SOFA monitoring.</strong> Studied 352 ICU patients
                    with serial SOFA measurements. Demonstrated that
                    <strong>ŒîSOFA during first 48h</strong> is strong predictor of mortality (ŒîSOFA
                    +1 point = ~10% ‚Üë mortality). Patients with SOFA ‚â•11 or increasing SOFA had
                    <strong>mortality rate >80%</strong>. Concluded serial assessment superior to
                    single admission SOFA for prognostication.
                  </p>
                </div>

                <div class="q-mb-md">
                  <p class="text-weight-bold">üìÑ Seymour CW, Liu VX, Iwashyna TJ, et al. (2016)</p>
                  <p class="q-ml-md text-grey-8">
                    "Assessment of Clinical Criteria for Sepsis: For the Third International
                    Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)"<br />
                    <em>JAMA</em>, 315(8): 762-774<br />
                    <strong>PMID: 26903335</strong><br />
                    <strong>Sepsis-3 validation study.</strong> Analyzed 148,907 patients with
                    suspected infection across 12 international datasets. Compared SOFA, SIRS, LODS,
                    qSOFA for predicting in-hospital mortality.
                    <strong>SOFA ‚â•2 points:</strong> AUROC 0.74 (95% CI 0.73-0.76), sensitivity 63%,
                    specificity 79% for mortality. <strong>qSOFA ‚â•2:</strong> AUROC 0.66 outside
                    ICU, faster bedside screening but lower sensitivity than SOFA.
                  </p>
                </div>

                <div class="q-mb-md">
                  <p class="text-weight-bold">üìÑ Raith EP, Udy AA, Bailey M, et al. (2017)</p>
                  <p class="q-ml-md text-grey-8">
                    "Prognostic Accuracy of the SOFA Score, SIRS Criteria, and qSOFA Score for
                    In-Hospital Mortality Among Adults With Suspected Infection Admitted to the
                    Intensive Care Unit"<br />
                    <em>JAMA</em>, 317(3): 290-300<br />
                    <strong>PMID: 28114553</strong><br />
                    <strong>Large ICU validation study.</strong> 184,875 ICU patients with suspected
                    infection from Australia/New Zealand ICU databases.
                    <strong>SOFA score:</strong> AUROC 0.753 for hospital mortality, superior to
                    SIRS (AUROC 0.589) and qSOFA (AUROC 0.690). Baseline SOFA ‚â•2 identified 93% of
                    ICU patients who died. Confirmed <strong>SOFA as best discriminator</strong> for
                    organ dysfunction and mortality in ICU sepsis.
                  </p>
                </div>

                <div class="q-mb-md">
                  <p class="text-weight-bold">
                    üìÑ Lambden S, Laterre PF, Levy MM, Francois B. (2019)
                  </p>
                  <p class="q-ml-md text-grey-8">
                    "The SOFA score‚Äîdevelopment, utility and challenges of accurate assessment in
                    clinical trials"<br />
                    <em>Critical Care</em>, 23(1): 374<br />
                    <strong>PMID: 31775846</strong><br />
                    <strong>Comprehensive SOFA review.</strong> Historical development from 1996
                    inception to Sepsis-3 integration. Discusses
                    <strong>challenges:</strong> sedation confounding CNS score, chronic organ
                    dysfunction baseline adjustments, inter-rater variability. Provides
                    recommendations for standardized SOFA calculation in clinical trials: worst
                    values per 24h window, sedation-free GCS when possible, document baseline SOFA
                    for chronic disease. Reviews validation data showing
                    <strong>consistent AUROC 0.74-0.86</strong> across diverse ICU populations.
                  </p>
                </div>

                <q-separator class="q-my-md" />

                <p class="text-weight-bold text-h6 q-mb-sm">Additional Key References</p>

                <ul class="q-ml-md">
                  <li>
                    <strong>Jones AE, Trzeciak S, Kline JA.</strong> (2009) "The Sequential Organ
                    Failure Assessment score for predicting outcome in patients with severe sepsis
                    and evidence of hypoperfusion at the time of emergency department presentation".
                    <em>Critical Care Medicine</em>, 37(5): 1649-1654.
                    <strong>PMID: 19325482</strong>. ED validation showing SOFA predicted mortality
                    better than APACHE II in sepsis patients.
                  </li>
                  <li>
                    <strong>Moreno R, Vincent JL, Matos R, et al.</strong> (1999) "The use of
                    maximum SOFA score to quantify organ dysfunction/failure in intensive care.
                    Results of a prospective, multicentre study". <em>Intensive Care Medicine</em>,
                    25(7): 686-696. <strong>PMID: 10470572</strong>. Maximum SOFA during ICU stay
                    predicts mortality (AUROC 0.86).
                  </li>
                  <li>
                    <strong>Rhodes A, Evans LE, Alhazzani W, et al.</strong> (2017) "Surviving
                    Sepsis Campaign: International Guidelines for Management of Sepsis and Septic
                    Shock: 2016". <em>Intensive Care Medicine</em>, 43(3): 304-377.
                    <strong>PMID: 28101605</strong>. Surviving Sepsis Campaign guidelines
                    recommending SOFA for sepsis diagnosis and monitoring.
                  </li>
                </ul>

                <q-separator class="q-my-md" />

                <q-banner class="bg-blue-1 text-blue-9" dense rounded>
                  <template v-slot:avatar>
                    <q-icon name="school" color="blue" />
                  </template>
                  <strong>Educational Note:</strong> These references represent peer-reviewed,
                  high-impact publications validating SOFA score. PMID citations allow direct PubMed
                  lookup. The SOFA score has been validated across >300,000 ICU patients in multiple
                  international cohorts, consistently demonstrating AUROC 0.74-0.86 for mortality
                  prediction. It remains the <strong>gold standard</strong> for quantifying organ
                  dysfunction in critically ill patients.
                </q-banner>
              </div>
            </q-card>
          </q-expansion-item>
        </q-card-section>
      </q-card>
    </div>
  </div>

  <div class="q-mt-lg">
    <q-banner class="bg-orange-1" rounded>
      <template v-slot:avatar>
        <q-icon name="warning" color="warning" />
      </template>
      <div class="text-caption">
        <strong>CLINICAL DISCLAIMER:</strong> SOFA Score is a prognostic tool, does not replace
        clinical assessment. Interpret in complete clinical context of the patient.
      </div>
    </q-banner>
  </div>
</template>
